The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
…
continue reading
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
…
continue reading
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a vid ...
…
continue reading
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Eva ...
…
continue reading
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email [email protected] or call our listener voicemail line at 206-984-3214.
…
continue reading
Your trusted partner in pharmaceutical manufacturing. We specialize in high-quality, innovative pharmaceutical products, ensuring healthcare solutions that meet global standards.
…
continue reading
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stak ...
…
continue reading
Your Brain On... is a podcast by Learning and Development professionals for Learning and Development professionals. Every day, Salience Learning combines the science of learning with expertise in the business of science to help solve the biopharma industry's most complex business challenges. Listen as hosts Karen Foster and Krista Gerhard discuss the latest in cognitive science and learning strategies as they relate to the ever-evolving healthcare industry. In other words: Your Brain On... g ...
…
continue reading
Tune in to industry innovators sharing real experiences – turning digital potential into a competitive advantage and improving patient outcomes. Previously known as Driving Digital in Biopharma.
…
continue reading
A thoughtful look at investing opportunities and risks beyond the market headlines, plus personal finance and retirement tips, from Morningstar.
…
continue reading
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
…
continue reading
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
…
continue reading
The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj AI Research CEO Daniel Faggella and team interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise
…
continue reading
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, ...
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
A collection of stories and insights on matters of discovery that advance life sciences. Brought to you by the curious people at Cytiva.
…
continue reading

1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation
David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist
The Go-to Podcast for Biotech Scientists Who Want to Master Biopharma CMC Development and Biomanufacturing. **TOP 10 LIFE SCIENCES PODCAST** Are you ready to simplify bioprocess development and scale with confidence to reduce time to market? Are you feeling overwhelmed by the complexity and guesswork of biologics development and biomanufacturing? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercializ ...
…
continue reading
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
…
continue reading
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
…
continue reading
Kurt Wehrle is a Chicago-based enterprising worldwide business pioneer with 20+ long periods of assorted and progressive P&L management in top-notch Biopharma, Medical Device, and Diagnostic organizations. Kurt Wehrle has a demonstrated history of creating multi-layered worldwide systems, building frameworks, changing business, extending topographies, and creating on the web capacities to essentially expand income and EBITDA.
…
continue reading
Hg sits at the centre of a universe of tech and software knowledge and expertise. We are constantly surprised by the ideas generated by these satellite minds and we want to share some of it with you. Join us for conversation with the experts, leaders and founders in our orbit.
…
continue reading
A myriad of AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health, a podcast by a16z Bio + Health and hosted by Kris Tatiossian and Olivia Webb, dives deep into the heart of biotechnology and healthcare innovation. Join veteran company builders, operators, and investors Vijay Pande, Julie Yoo, Vineeta Agarwala, and Jorge Conde, along with distinguished guests like Mark Cuban, Greg ...
…
continue reading
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
…
continue reading
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
…
continue reading
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team an ...
…
continue reading
Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 20k monthly views. Free. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Nielsen @BII, Edwin Moses, Bahija Jallal @Immunocore, and more. Your host Philip animates the conver ...
…
continue reading
Austin's evolution into a global innovation superstar is at the heart of Austin Next. We uncover insights into the region's transformation and what it means for ecosystem building. Our exploration extends to emerging trends, technologies, and their convergence. Using Austin as our real-world case study and experts from around the world, we aim to understand the true nature and mechanics of innovation.
…
continue reading
Gregory Austin and Dr. Chad Briscoe unzip, unlock, and uncover, the Stories Behind Medical Progress by sharing the latest and greatest advances in biopharmaceuticals and medical technologies in a fun, entertaining, and enlightening interview format. We bring on innovative leaders across the life sciences. The format is like a conversation you might overhear at the bar or at dinner after a day of great life science talks at a conference, engaging and accessible.
…
continue reading
Presented by Kymanox, Life Science Solutions is dedicated to accelerating understanding and advancing expertise in the life sciences industry. Focused on bringing industry insights to light, our podcast offers a platform where regulatory, scientific, and engineering experts share practical knowledge on overcoming the challenges of product development and commercialization. Episodes equip listeners with the latest on regulatory updates, market trends, cutting-edge technology, and more. Join u ...
…
continue reading
The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.
…
continue reading
LARVOL & Friends is a must-listen for anyone interested in hearing about insights and exclusive takes from industry experts and business leaders about the evolution, intersection and future of biopharma, technology, business, and competitive intelligence! Since 2004, LARVOL has been accelerating decision-making by providing real-time, customized intelligence and software solutions with data-driven analytics to the most prominent pharmaceutical, biotech, and healthcare companies in the world. ...
…
continue reading
Lab Rats to Unicorns is a podcast that aims to demystify the process of creating a great company in life sciences. Under the guidance of our host, John Flavin, you will hear personal stories of creation, be able to understand how great companies are created, and get insights into the many ways that you as an individual can engage in the creation of tomorrow’s life science companies. From the lab rat, signifying the process of invention and discovery, to the unicorn, signifying market success ...
…
continue reading
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
HedgeD, with a capital “D” for emphasis, brings listeners topical content from both sides of the ledger – the long side and the short side. In each episode, co-hosts Mark Yusko, Cory Lester and Andrew Schmeelk take a deep dive into an investment theme or concept, typically with the help of an expert guest from Morgan Creek’s expansive global network.
…
continue reading

1
Rare Insights: Uncovering The Future Of Rare Disease Treatments
Know Rare (Taren Grom, Liz Kay, Kaitlyn Taylor, Nina Wachsman, and DNA Today’s Kira Dineen)
On “Rare Insights” we bridge the gap between those living with rare diseases and the biopharmaceutical industry. Know Rare amplifies the voices of individuals with rare conditions, providing invaluable perspectives to accelerate therapeutic solutions. Join us as we dive deep into the complexities of rare diseases, exploring real-world insights from passionate industry leaders. Together, we navigate the unknowns and unlock the potential for groundbreaking treatments. Because in this journey, ...
…
continue reading
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantical ...
…
continue reading
What are the biggest challenges and opportunities facing the life sciences sector? How can we overcome these challenges while unlocking the opportunities? Join host Stuart Lowe and a roster of expert guests as they unpack the past, present and future of cell and gene therapy.
…
continue reading
The lastest news in AI and Life Sciences
…
continue reading
Weekly podcast exploring China's business and financial sectors from a legal perspective, brought to you by China Law & Practice. Hosted by Vincent Chow.
…
continue reading
Tune into our new Pharmaceuticals and Life Sciences podcast to hear the latest insights from Baringa's experts.
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading
Lean by Design delves into the dynamic world of biotech, pharma, and life sciences, focusing on operational excellence through effective workflow and process optimization. Join hosts Oscar Gonzalez and Lawrence Wong as they engage with industry leaders who share their insights, innovative strategies, and real-world experiences in transforming complex challenges into streamlined, efficient solutions. Through thought-provoking conversations, you’ll gain practical tips and inspiration to drive ...
…
continue reading
The world of pharmaceutical careers can be dynamic and sometimes overwhelming—but it doesn’t have to be! With nearly a decade in medical affairs, a bioscience master’s degree, and a background in medcomms, I’m here to make your transition into pharma exciting, accessible, and rewarding. Whether you're considering a career change, moving from an agency to pharma, or coming from a clinical or bioscience background, this podcast is designed for you. I’ll share my own experiences—from earning a ...
…
continue reading

1
Building Biotech at the Interface: Geoff Duyk on Genomics, Platforms, and Grove Biopharma_e.67
1:23:34
1:23:34
Play later
Play later
Lists
Like
Liked
1:23:34In this episode of Lab Rats to Unicorns, host John Flavin speaks with Dr. Geoff Duyk, co-founder and CEO of Grove Biopharma. Geoff brings over 35 years of experience across academia, biotech leadership, and venture capital. From his early work in human genetics at UCSF to co-founding Millennium Pharmaceuticals and leading R&D at Exelixis, Geoff unp…
…
continue reading

1
Two CEOs discuss bracing for tariffs, NIH grant cuts and gifting China biopharma leadership position
31:12
31:12
Play later
Play later
Lists
Like
Liked
31:12As pharma deals with the impact of NIH grant cuts and what could follow with the imposition of tariffs, Robert Williams, chief operating officer of Triumvira Immunologics Inc., and Hernan Bazan, CEO of South Rampart Pharma LLC, brought their extensive experience in the industry to the podcast. Their concerns include how tariffs will bring lower mar…
…
continue reading

1
Christophe Bourdon, LEO Pharma 🇩🇰 | Biopharma Turnaround | E31
50:47
50:47
Play later
Play later
Lists
Like
Liked
50:47We’re in Copenhagen 🇩🇰 with Christophe Bourdon, the CEO who turned a 116-year-old biopharma company from the brink of failure to success.We discuss the lessons behind the turnaround, innovation in dermatology, especially biologicals and I&I, and living in eight different countries.⭐️ ABOUT THE SPEAKERChristophe Bourdon came to be CEO of LEO Pharma …
…
continue reading

1
Q1 biopharma layoff trends, plus expectations for Q2
11:29
11:29
Play later
Play later
Lists
Like
Liked
11:29In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson discuss how workforce reductions impacted the biopharma industry in the first quarter. The pair examine industry trends, company closures, developments in the cell and gene space—and the reductions in force happening at feder…
…
continue reading

1
🧬Alfredo Andere - LatchBio: Revolutionizing Biopharma Data & Mastering Enterprise Sales (Part 4/4)
46:25
46:25
Play later
Play later
Lists
Like
Liked
46:25🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading

1
AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals
26:36
26:36
Play later
Play later
Lists
Like
Liked
26:36Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI is improving drug development efficiency, addressing data challenges, and …
…
continue reading

1
2025 Health Trends | AI as an R&D Investment
24:09
24:09
Play later
Play later
Lists
Like
Liked
24:092025 Health Trends meets The Syneos Health Podcast for a limited series exploring how Trends come alive in the life sciences industry with host Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions. Syneos Health experts Brian Carver, Executive Director of Therapeutic Strategy and Innovation, Rare Disease Consortiu…
…
continue reading

1
🧬 Redefining Biotech: Building Enduring Value Beyond Acquisition | Rabia Khan (Part 4/4)
48:44
48:44
Play later
Play later
Lists
Like
Liked
48:44🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading
Vinod Das, Pharma R&D, Drug Innovation & AI Scouting for Bayer; sits down with Nagaraja Srivatsan to discuss the integration of generative AI in drug discovery and clinical development. He discusses the journey of AI adoption, the importance of prompt engineering, and the complexities of implementation.…
…
continue reading

1
148: Lab-Grown Blood: How Stem Cells Transform Transfusions with Ari Gargir - Part 2
16:17
16:17
Play later
Play later
Lists
Like
Liked
16:17Send us a text In the wake of the COVID-19 pandemic, the fragility of global blood supply systems became undeniably clear. Recognizing the urgent need for a more reliable and universal solution, Ari Gargir and his team at RedC Biotech are leading an ambitious effort to transform blood supply as we know it. Their mission? To develop lab-grown red bl…
…
continue reading

1
Asembia AXS25 Series: Navigating Modern Market Access
13:08
13:08
Play later
Play later
Lists
Like
Liked
13:08The biopharma market is booming—but not without turbulence. In this kickoff episode of our special podcast series in collaboration with Asembia, hosts Michael Sarshad, Managing Director, Commercial Advisory, Syneos Health and Sara Rubin, Senior Vice President, Market Access Strategy at Spherico, a Syneos Health company, unpack the dynamic forces re…
…
continue reading

1
Steve Usdin: Tariffs, Price Controls, & Inflation Reduction Act (IRA)
56:35
56:35
Play later
Play later
Lists
Like
Liked
56:35In this episode, host Duane Schulthess sits down with Steve Usdin, Senior Washington Editor at BioCentury Publications since 1993 and one of the most cited experts on FDA regulation, Medicare policy and the political forces driving biopharma innovation, to explore the major forces reshaping U.S. life sciences: looming Section 232 tariff probes, the…
…
continue reading

1
Precision Medicine in Liver Treatment: The Ochre Bio Approach
28:23
28:23
Play later
Play later
Lists
Like
Liked
28:23Ochre Bio co-founder and CSO Quin Wills spoke with In Vivo about the UK-based company's novel approach to finding and validating RNA therapies for chronic liver diseases.By Citeline
…
continue reading

1
Capturing Venture Capital: What Makes Life Science Startups Stand Out to Investors
27:52
27:52
Play later
Play later
Lists
Like
Liked
27:52In this special episode recorded live at CED Venture Connect, host Chris Adkins sits down with Dave Ousterout, Co-Founder and General Partner at CapeFear Biocapital. Drawing from his unique journey as both a biotech entrepreneur and now a venture capital investor, Dave shares what it really takes to stand out in the early-stage life sciences space.…
…
continue reading

1
E162 | How AI can simplify CNS participant screening for Alzheimers and Parkinsons
35:28
35:28
Play later
Play later
Lists
Like
Liked
35:28In this must-listen episode, Dr. Andre Bates sits down with James Hamet, founder and CEO of Vistim Labs, as he unveils a groundbreaking EEG technology that could transform how we understand and treat neurodegenerative diseases like Alzheimer's and Parkinson's. In this eye-opening edition of AI for Business Growth, Hamet reveals a cutting-edge brain…
…
continue reading

1
Joris Pezzini, Alira Health | Hottest Biotech Insights | E32 [Sponsored]
1:10:41
1:10:41
Play later
Play later
Lists
Like
Liked
1:10:41We’re in Barcelona 🇪🇸 with Joris Pezzini from Alira Health to discuss the hottest biotech insights right now, including obesity, I&I, radiopharmaceuticals and ADCs.---This episode is sponsored by Alira Health, an advisor and clinical development partner for life sciences companies. Learn more at https://bit.ly/alirahealth-flotbio-1---⭐️ ABOUT THE S…
…
continue reading

1
Driving Multi-Modal Retail and Healthcare CX - with Brett Kiley of CVS Health
18:38
18:38
Play later
Play later
Lists
Like
Liked
18:38In this episode of the AI in Business Podcast, Brett Kiley, Executive Director of Customer Experience and Client Solutions at CVS Health, joins us for a compelling discussion on the evolving landscape of customer interactions. With over two decades of experience, Brett shares how CVS navigates the challenges of personalization, efficiency, and seam…
…
continue reading

1
147: Lab-Grown Blood: How Stem Cells Transform Transfusions with Ari Gargir - Part 1
22:01
22:01
Play later
Play later
Lists
Like
Liked
22:01Send us a text Blood is critical to global healthcare - vital for surgeries, trauma care, cancer treatment, and maternal health. Yet despite 120 million donations each year, a 100 million unit shortfall means nearly half the world’s needs go unmet. One person who understands this crisis firsthand is Ari Gargir, CEO & Founder of RedC Biotech. After …
…
continue reading

1
Thermo Fisher opens cell therapy center, FDA cites Aurobindo site, Trump probes pharma imports ahead of tariffs [The good, the bad, the ugly]
4:13
4:13
Play later
Play later
Lists
Like
Liked
4:13The good — Thermo Fisher opens center to boost cell therapy development The bad — FDA cites Aurobindo plant after Raleigh inspection The ugly — Trump probes pharma imports as tariff threat loomsBy Pharma Manufacturing
…
continue reading

1
Healthcare Leadership and Resilience with Grace Magedman
45:31
45:31
Play later
Play later
Lists
Like
Liked
45:31In this powerful and deeply human episode of RealPharma, we’re joined by Grace Magedman, PharmD—former Chief Pharmacy Officer at Children’s Hospital of Orange County, functional medicine practitioner, and founder of The Magidman Group. Grace takes us inside her 20+ years of hospital pharmacy leadership, where she navigated high-stakes medication de…
…
continue reading

1
🧬 Sales Skills & Resilience: Hidden Drivers of Biotech Success | Rabia Khan (Part 3/4)
38:28
38:28
Play later
Play later
Lists
Like
Liked
38:28🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading

1
The Implications Of China's Growing Biotech Industry With Allan Shaw
46:08
46:08
Play later
Play later
Lists
Like
Liked
46:08We love to hear from our listeners. Send us a message. Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse. Increased deal activity with Chinese biopharmaceutical companies is injecting new risk into traditional development models in the We…
…
continue reading

1
Scrip's Five Must-Know Things - 21 April 2025
16:18
16:18
Play later
Play later
Lists
Like
Liked
16:18Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 April 2025. In this episode: Trump’s drug pricing executive order; J&J says taxes, not tariffs, influence US manufacturing; Pfizer discontinuation sparks M&A speculation; US tariffs and manufacturing concentration; and tariffs’ pressures on pharma’s comp…
…
continue reading
After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companies, manufacturers and other outfits across the life sciences spectrum are still scrambling to respond to mounting trade pressures. While many unknowns remain, biopharma companies should waste no time in starting to evaluate their o…
…
continue reading

1
Market Volatility: Which Investments Will Protect Your Portfolio in a Recession?
13:26
13:26
Play later
Play later
Lists
Like
Liked
13:26Amy Arnott, Morningstar Inc. portfolio strategist, discusses which investments have performed best and worst in past recessions. Gold prices are rising during the current market volatility. Arnott explains why it might not be the best time to buy the precious metal. Key Takeaways: Why Current Market Volatility May Not Be Ending Soon How to Keep You…
…
continue reading

1
Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls
24:56
24:56
Play later
Play later
Lists
Like
Liked
24:56Summary:At the heart of any successful self-care business is a portfolio of recognizable and trusted consumer health brands. These brands could play a key role in unlocking the potential of digital self-care in the UK, suggests Michelle Riddalls, in this second part of her Over the Counter interview. As PAGB CEO, Michelle has seen first had how the…
…
continue reading

1
A golden age of software engineering with Russell Kaplan, Founding President of Cognition
39:53
39:53
Play later
Play later
Lists
Like
Liked
39:53What happens when AI can code? In this illuminating conversation with Cognition's Founding President Russell Kaplan, we explore how AI is fundamentally transforming the landscape of software development. Drawing from his journey through Tesla's Autopilot team and Scale AI, Kaplan shares profound insights on leadership in rapid technological change,…
…
continue reading

1
🧬 Rabia Khan - Serna Bio: Bridging Science & Tech—PhDs, MBAs, & Biotech Innovation (Part 2/4)
45:29
45:29
Play later
Play later
Lists
Like
Liked
45:29🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading

1
146: Beyond ELISA: The 10-Minute Immunoassay Enabling Real-Time Bioprocess Control with Bruno Oesch - Part 2
18:09
18:09
Play later
Play later
Lists
Like
Liked
18:09Send us a text Stuck with outdated analytics while trying to develop cutting-edge therapies? Part 2 of our conversation with Bruno Oesch, CEO and founder of Elionova, reveals how biotech scientists can finally break free from incremental improvements and embrace the revolutionary immunoassay technology that's transforming bioprocessing workflows wo…
…
continue reading

1
Ep. 82 – Act Now or Fall Behind: Michelle Rozo on Biotech’s National Security Stakes
31:01
31:01
Play later
Play later
Lists
Like
Liked
31:01The U.S. will cede its preeminence in biotechnology to China within three years unless the government acts urgently, an independent commission chartered by Congress warns. “Our window to act is closing,” the National Security Commission on Emerging Biotechnology said in a newly released report. “We need a two-track strategy: make America innovate f…
…
continue reading

1
Atlanta Rising: Science, Innovation, and the Future of Biotech with Steven Goudy and Ashley Cornelison_e.66
51:48
51:48
Play later
Play later
Lists
Like
Liked
51:48In this episode of Lab Rats to Unicorns, we sit down with two powerhouse leaders advancing the life sciences movement in Atlanta: Dr. Steven Goudy, a pediatric otolaryngologist at Emory University and founder/CEO of Oridivus, and Ashley Cornelison, Executive Director of Portal Innovations Atlanta and a longtime champion of biotech startups in the S…
…
continue reading

1
E161 | How GenAI can change medical imaging
33:12
33:12
Play later
Play later
Lists
Like
Liked
33:12In this must-listen episode, Dr. Andre Bates sits down with Soner Hacihaliloglu, founder and CEO of PONS Tech, to explore how Generative AI (GenAI) and ultrasound technology are combining to radically improve medical imaging, early detection, and preventive healthcare. 🚀 Key Takeaways: How AI-driven image enhancement is solving the challenges of lo…
…
continue reading

1
Global AI Regulations and Their Impact on Industry Leaders - with Micheal Berger of Munich Re
21:01
21:01
Play later
Play later
Lists
Like
Liked
21:01Today’s guest is Michael Berger, Head of Insure AI at Munich Re. Michael returns to the Emerj podcast platform to discuss the impact of legislation such as the EU AI Act on the insurance industry and broader AI adoption. Our conversation covers how regulatory approaches differ between the United States and the European Union, highlighting the risk-…
…
continue reading

1
The (Epic) Arc of a Patient Journey with Seth Hain
26:00
26:00
Play later
Play later
Lists
Like
Liked
26:00Seth Hain, SVP of R&D at Epic, joins a16z Bio + Health general partner Julie Yoo to explore technology in healthcare. Reflecting on over two decades of industry shifts, Seth shares how Epic has transitioned from enabling integrated systems within health systems to driving cross-ecosystem collaboration and rapid innovations like generative AI. They …
…
continue reading

1
145: Beyond ELISA: The 10-Minute Immunoassay Enabling Real-Time Bioprocess Control with Bruno Oesch - Part 1
27:19
27:19
Play later
Play later
Lists
Like
Liked
27:19Send us a text Tired of waiting overnight for ELISA results? Serial entrepreneur Bruno Oesch reveals how his groundbreaking 10-minute immunoassay technology is eliminating the biggest bottleneck in bioprocessing workflows. From contributing to Nobel Prize-winning prion research to founding Prionics (the first commercial BSE test) and now revolution…
…
continue reading

1
Endless Frontiers and the Future of American Innovation with Jordan Blashek, Managing Director America's Frontier Fund
1:16:14
1:16:14
Play later
Play later
Lists
Like
Liked
1:16:14At a hinge point when tech leadership determines the balance of geopolitical power, deep tech investment has never been more critical to America's future. Jordan Blashek, co-founder of America's Frontier Fund, brings his perspective on innovation for national advantage. From investing in defense tech to the newly launched Endless Frontiers, we disc…
…
continue reading

1
Novartis to invest $23B in US sites, US urged to invest $15B in biotech counter to China, Trump warns of major pharma tariffs [The good, the bad, the ugly]
4:10
4:10
Play later
Play later
Lists
Like
Liked
4:10Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week: The good — Novartis to invest $23B in U.S. manufacturing and R&D, including seven new sites The bad — U.S. urged to invest $15B to counter China’s biotech rise The ugly — Trump signals ‘major’ tariffs on pharm…
…
continue reading

1
Ep177: Kevin Parker on Finding Cancer Drug Targets
58:13
58:13
Play later
Play later
Lists
Like
Liked
58:13Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.By Timmerman Report
…
continue reading

1
How To Be A CFO With Insmed's Sara Bonstein
44:20
44:20
Play later
Play later
Lists
Like
Liked
44:20We love to hear from our listeners. Send us a message. On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to lead teams, especially when those teams have deeper subject matter expertise. Other topics discussed include when to make …
…
continue reading

1
🧬 Rabia Khan - Serna Bio: Unraveling the Genetics of AI-Driven Drug Discovery (Part 1/4)
48:30
48:30
Play later
Play later
Lists
Like
Liked
48:30🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading

1
Scrip's Five Must-Know Things - 14 April 2025
16:10
16:10
Play later
Play later
Lists
Like
Liked
16:10Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 April 2025. In this episode: Trump’s tariff rollercoaster; regulatory, economic uncertainties hang over Q1 earnings; IPOs rise in Q1 but may slow; Chinese deal-making matures; and AstraZeneca talks about Chinese innovation. https://insights.citeline.com/…
…
continue reading

1
Project Optimus Series: The Role of Biostatistics
17:26
17:26
Play later
Play later
Lists
Like
Liked
17:26As regulatory expectations evolve under the FDA’s Project Optimus oncology dosing initiative, biostatistics is emerging as a central pillar in designing and executing trials that move beyond the traditional maximum tolerated dose (MTD) approach. In this fourth episode of our Project Optimus series, host Dr. Wael Harb is joined by biostatistics expe…
…
continue reading

1
Market Volatility: What Lies Ahead in Trump's Trade War
13:03
13:03
Play later
Play later
Lists
Like
Liked
13:03Dominic Pappalardo, chief multi-asset strategist for Morningstar Investment Management, discusses the escalating US-China trade war, the 90-day tariff pause, and raised recession risk during this market volatility. Key Takeaways: What an Escalating Trade War Between the US and China Could Mean Macroeconomic Trends and Rising Deglobalization After T…
…
continue reading

1
미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)
3:58
3:58
Play later
Play later
Lists
Like
Liked
3:58미국이 수입 의약품에 관세를 부과할 가능성은 여전하지만, 트럼프의 최근 발표로 인해 이를 시행하는 데 시간이 더 걸릴 수 있다는 Pink Sheet (Citeline Regulatory) 기사를 요약한 내용입니다.https://insights.citeline.com/pink-sheet/compliance/distribution-supply-chain/pharma-still-nervous-while-riding-trumps-tariff-rollercoaster-DFQMWLGXSZBS3K34UY2OE6TUVA/Playlist: soundcloud.com/citelinesounds/sets/korean-language-bio…
…
continue reading

1
Transforming Cancer Care in India with AI
36:10
36:10
Play later
Play later
Lists
Like
Liked
36:10Vijayalakshmi Ramshankar, professor and head of the Department of Cancer Biology and Molecular Diagnostics at Cancer Institute (WIA) sits down with Nagaraja Srivatsan to discuss the cancer research landscape in India, the work she is doing to leverage AI to improve diagnosis and outcomes, and the future of AI in oncology…
…
continue reading

1
144: The Future of Biotech: Making Biotherapeutics More Accessible Faster
12:55
12:55
Play later
Play later
Lists
Like
Liked
12:55Send us a text Imagine a future where every patient can access life-saving therapies and sustainable, high-quality food is within everyone’s reach. In this episode of the Smart Biotech Scientist, David Brühlmann explores how innovative biotech developments are making this vision a reality. Here’s a sneak peek of the breakthroughs covered: AI-Powere…
…
continue reading

1
From Semiconductors to AI Ecosystems with Tyson Tuttle, Founder and CEO Circuit
1:13:30
1:13:30
Play later
Play later
Lists
Like
Liked
1:13:30From cutting-edge chips to AI networks the disruption happening up and down the tech stack is upending invention and value. Everything is on the table. Tyson Tuttle, former CEO of Silicon Labs and current founder and CEO of Circuit, brings decades of experience building innovative products across multiple tech waves. In this conversation, Tyson sha…
…
continue reading

1
E160 | From Bio-Tech to Tech-Bio: AI Meets Drug Discovery
38:50
38:50
Play later
Play later
Lists
Like
Liked
38:50Welcome to an eye-opening conversation at the intersection of artificial intelligence and biotechnology. In this episode, we explore how AI is redefining protein design, accelerating drug discovery, and personalizing medicine at scale. Joining us is Brian Keane, Chairman of the Board at Diagen AI — a trailblazing Canadian company using AI-powered m…
…
continue reading